Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
4,502,840
-
Share change
-
+3,570,232
-
Total reported value
-
$345,999,696
-
Put/Call ratio
-
24%
-
Price per share
-
$76.84
-
Number of holders
-
90
-
Value change
-
+$274,153,350
-
Number of buys
-
60
-
Number of sells
-
17
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2022
As of 30 Jun 2022 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,502,840 shares of stock of the company.
Largest 10 holders included Phoenix Holdings Ltd., UBS Group AG, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Noked Capital LTD, Noked Israel Ltd, BANK OF AMERICA CORP /DE/, ALTFEST L J & CO INC, ROYAL BANK OF CANADA, and JANE STREET GROUP, LLC.
This table shows 90 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.